PF-06263276: Clinical Trials

1 trial of PF-06263276, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow PF-06263276: new trials by email Literature Review of PF-06263276 trials Research Report on PF-06263276

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis
PF06263276, Vehicle, 2%Tofacitinib Ointment - Psoriasis Vulgaris
Phase 1CompletedPfizer152014-09-012016-06-09

Conditions studied

Plaque, Amyloid (1)  ·  Psoriasis (1)

Sponsors

Pfizer (1)

Countries

Germany (1)

NIH funding

2014 (1)